Full Event Guide

Access Your Copy of the Agenda to Discover

New Deep Discussion Workshops

Gain valuable insights into mechanisms of allogeneic rejection, strategic donor sourcing, expansion into solid tumors, and controlled expansion for scalable manufacture

Expanded Speaker & Company Line-up

Connect with 16+ new companies and new pioneering speakers, at industry leading companies including GentiBio, Bristol Myers Squibb, and Tr1x

Streamlined Agenda

 2 content-filled tracks dedicated to Preclinical Development and Manufacturing & Process Development

New Deep Discussion Workshops

Gain valuable insights into mechanisms of allogeneic rejection, strategic donor sourcing, expansion into solid tumors, and controlled expansion for scalable manufacture

Expanded Speaker & Company Line-up

Connect with 16+ new companies and new pioneering speakers, from industry leading companies including GentiBio, Bristol Myers Squibb, and Tr1x

Streamlined Agenda

 2 content-filled tracks dedicated to Preclinical Development and Manufacturing & Process Development

Allogeneic Cell Therapies - Agenda 2025

Having trouble downloading the brochure? Let us know and we will email you a PDF copy across instead.

Companies on the Program Include

Allogeneic Cell Therapies - Companies on the program

"This was the first conference I attended, and I had a great time. I enjoyed how friendly and collaborative everyone was. It was an environment where everyone could come together and discuss and learn together regardless of background”

Sana Biotechnology, 2024 Attendee